Paradigm’s Post

View organization page for Paradigm, graphic

4,699 followers

Our leadership team is in Israel today announcing a groundbreaking partnership with Sheba Medical Center, Tel Hashomer and ARC Innovation. We are honored to be part of this announcement highlighting Sheba’s ongoing leadership in #clinicaltrials and the role Paradigm will play in supporting the scaling of clinical trials throughout Israel, and the development of a global clinical trials network with Sheba and ARC. Sheba Medical Center is Israel's largest hospital and a well-established leader in clinical trials. Through the deployment of our platform, we will help extend Sheba’s reach, efficiency, and capabilities across Sheba and their affiliated clinics. We’ll be collaborating to streamline trial operations, including feasibility assessments, patient screening, recruitment, and data collection. Sheba is a hugely in-demand location for biopharma trials, and our work together will expand their capacity by lowering the administrative burden of trials. That means more patients will have access to innovative treatments, and providers will be able to spend more time focusing on patient care rather than paperwork. We're grateful for the trust of ARC Innovation and Sheba Medical Center, and honored to help serve their patients. From Israel to Japan to North Dakota and beyond, we're building a new, end-to-end clinical trials platform and changing the paradigm for patient care and clinical trial access globally. Read more: https://lnkd.in/enaTjx9j

  • Professor Eyal Zimlichman, MD, Chief Innovation and Transformation Officer at Sheba Medical Center and Founder and Director of ARC Innovation, Kent Thoelke, CEO of Paradigm, and Jonathan Hirsch,
Chief Strategy and Growth Officer at Paradigm.
Todd Mayover, Esq., CIPP/E, CIPP/US

Global Data Privacy, Artificial Intelligence & Compliance Leader | Expert in Building & Operationalizing Privacy Programs for Biotech, Healthcare, Life Sciences and Pharma Companies | Fractional General Counsel

1mo

Amazing news, Paradigm! Congrats!

Like
Reply

To view or add a comment, sign in

Explore topics